Does NATALIZUMAB Cause Flushing? 348 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 348 reports of Flushing have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.5% of all adverse event reports for NATALIZUMAB.
348
Reports of Flushing with NATALIZUMAB
0.5%
of all NATALIZUMAB reports
1
Deaths
46
Hospitalizations
How Dangerous Is Flushing From NATALIZUMAB?
Of the 348 reports, 1 (0.3%) resulted in death, 46 (13.2%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Flushing Listed in the Official Label?
Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for NATALIZUMAB.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which NATALIZUMAB Alternatives Have Lower Flushing Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK